Since the first 46,XY DSD patient with a pathological NR5A1 variant was described by Achermann et al. (4), the spectrum of clinical presentation has evolved from the mildest to the most severe form including adrenal insufficiency as a potentially life-threatening complication. The gene discussed is NR5A1; the disease is Adrenal insufficiency.